{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:20:59Z","timestamp":1760239259491,"version":"build-2065373602"},"reference-count":10,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Lung cancer (LC) is inarguably one of the biggest battles to be fought in the field of oncology, and non-small cell lung cancer accounts for over 85% of all lung cancer cases [...]<\/jats:p>","DOI":"10.3390\/jcm9103376","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T20:51:00Z","timestamp":1603399860000},"page":"3376","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Biomarkers for Non-Small Cell Lung Cancer: From the Bench to the Bedside"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9640-4573","authenticated-orcid":false,"given":"Ramon Andrade","family":"de Mello","sequence":"first","affiliation":[{"name":"Algarve Biomedical Centre, Department of Biomedical Sciences and Medicine University of Algarve (DCBM UALG), 8005-139 Faro, Portugal"},{"name":"Division of Medical Oncology, Escola Paulista de Medicina, Federal University of S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo 04037-004, Brazil"},{"name":"Precision Oncology and Health Economics Group (ONCOPRECH), Post-Graduation Program in Medicine, Nine of July University (UNINOVE), S\u00e3o Paulo 01525-000, Brazil"}]},{"given":"Giovanna Ara\u00fajo","family":"Amaral","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Escola Paulista de Medicina, Federal University of S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo 04037-004, Brazil"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.291.14.1763","article-title":"Lung Cancer in US Women: A Contemporary Epidemic","volume":"291","author":"Patel","year":"2004","journal-title":"JAMA"},{"key":"ref_3","first-page":"1023","article-title":"Quality of life of patients with lung cancer","volume":"9","author":"Polanski","year":"2016","journal-title":"Onco Targets Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cllc.2017.02.008","article-title":"Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer","volume":"8","author":"Morrison","year":"2017","journal-title":"Clin. Lung Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Jeon, S.M., Kwon, J.W., Choi, S.H., and Park, H.Y. (2019). Economic burden of lung cancer: A retrospective cohort study in South Korea, 2002\u20132015. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0212878"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lungcan.2005.06.005","article-title":"The economic burden of lung cancer and the associated costs of treatment failure in the United States","volume":"50","author":"Kutikova","year":"2005","journal-title":"Lung Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1158\/1055-9965.EPI-11-0650","article-title":"Economic burden of cancer in the United States: Estimates, projections, and future research","volume":"20","author":"Yabroff","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_8","first-page":"923","article-title":"Evolution of non-small cell lung cancer chemotherapy (Review)","volume":"13","author":"Dimitroulis","year":"2005","journal-title":"Oncol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3332\/ecancer.2017.787","article-title":"Non-small cell lung cancer treatment (r)evolution: Ten years of advances and more to come","volume":"11","author":"Toschi","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrclinonc.2011.126","article-title":"Personalized medicine in lung cancer: What we need to know","volume":"8","author":"Mok","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/10\/3376\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:25:32Z","timestamp":1760178332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/10\/3376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":10,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["jcm9103376"],"URL":"https:\/\/doi.org\/10.3390\/jcm9103376","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2020,10,21]]}}}